NCT05818410 Human-Prosthetic Interaction: Brain & Technology After Lower-Limb Loss
| NCT ID | NCT05818410 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vrije Universiteit Brussel |
| Condition | Lower Limb Amputation Below Knee (Injury) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-01-16 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-01-16 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates brain neuroplasticity and functional performance in people with unilateral lower limb amputation.
Eligibility Criteria
Inclusion Criteria: * Unilateral transtibial (below knee) amputation * Healthy subject * Medicare Functional Classification Level: K3-4 Exclusion Criteria: * Any neurological disease * Upper limb or bilateral amputation * Osso-integration * Metal implants * Diabetes
Contact & Investigator
Kevin De Pauw
PRINCIPAL INVESTIGATOR
Vrije Universiteit Brussel
Frequently Asked Questions
Who can join the NCT05818410 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lower Limb Amputation Below Knee (Injury). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05818410 currently recruiting?
Yes, NCT05818410 is actively recruiting participants. Contact the research team at Kevin.De.Pauw@vub.be for enrollment information.
Where is the NCT05818410 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT05818410 clinical trial?
NCT05818410 is sponsored by Vrije Universiteit Brussel. The principal investigator is Kevin De Pauw at Vrije Universiteit Brussel. The trial plans to enroll 60 participants.